Oaktree Specialty Lending (Oaktree Specialty Lending) Change In Working Capital

: $-14.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

Oaktree Specialty Lending's change in working capital for the quarter that ended in Dec. 2023 was $107.0 Mil.

Oaktree Specialty Lending's change in working capital for the fiscal year that ended in Sep. 2023 was $-107.4 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Oaktree Specialty Lending Change In Working Capital Historical Data

The historical data trend for Oaktree Specialty Lending's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oaktree Specialty Lending Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Change In Working Capital

41.24

-59.80

21.20

-71.41

-107.40

Oaktree Specialty Lending Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Working Capital																13.61	-67.62	-13.54	-39.86	106.98

Oaktree Specialty Lending Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Oaktree Specialty Lending Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Oaktree Specialty Lending's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Oaktree Specialty Lending (Oaktree Specialty Lending) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Oaktree Specialty Lending Corp (NAS:OCSL) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

FFC:Germany

Address

333 South Grand Avenue, 28th Floor, Los Angeles, CA, USA, 90071

Website

https://www.oaktreespecialtylending.com

Oaktree Specialty Lending Corp is a specialty finance company. It provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. Its investments generally range in size from ten million dollars to hundred million dollars and are principally in the form of the first lien, second lien, or collectively, senior secured, and subordinated debt investments, which may also include an equity component made in connection with investments by private equity sponsors.

Executives

Matthew Stewart	officer: Chief Operating Officer	C/O OAKTREE CAPITAL MANAGEMENT, L.P., 333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES CA 90071
Christopher Mckown	officer: See Remarks	C/O OAKTREE CAPITAL MANAGEMENT, L.P., 333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES CA 90071
Phyllis R Caldwell	director	AMERICAN CAPITAL, LTD., 2 BETHESDA METRO CENTER, 12TH FLOOR, BETHESDA MD 20814
Ashley Pak	officer: Chief Compliance Officer	C/O OAKTREE CAPITAL MANAGEMENT, L.P., 333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES CA 90071
Mathew Pendo	officer: Chief Operating Officer	C/O OAKTREE CAPITAL MANAGEMENT, L.P., 333 S. GRAND AVENUE, 28TH FLOOR, LOS ANGELES CA 90071
Leonard M Tannenbaum	director, officer: CEO and President	525 OKEECHOBEE BLVD., SUITE 1770, WEST PALM BEACH FL 33401
Deborah Ann Gero	director	333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES CA 90071
Richard Ruben	director	C/O OAKTREE CAPITAL MANAGEMENT, L.P., 333 S. GRAND AVENUE, 28TH FLOOR, LOS ANGELES CA 90071
Armen Panossian	officer: Chief Executive Officer	333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES CA 90071
Craig A Jacobson	director	C/O EXPEDIA, INC., 333 108TH AVENUE NE, BELLEVUE WA 98004
Melvin Carlisle	officer: Chief Financial Officer	C/O OAKTREE CAPITAL MANAGEMENT, L.P., 333 S. GRAND AVENUE, 28TH FLOOR, LOS ANGELES CA 90071
Bruce Zimmerman	director	C/O OAKTREE CAPITAL MANAGEMENT, L.P., 333 S. GRAND AVENUE, 28TH FLOOR, LOS ANGELES CA 90071
Marc Gamsin	director	1999 AVENUE OF THE STARS, SUITE 2150, LOS ANGELES CA 90067
John Frank	director	C/O OAKTREE CAPITAL MANAGEMENT, 333 SOUTH GRAND 28TH FLOOR, LOS ANGELES CA 90071
Edgar Lee	officer: See Remarks	C/O OAKTREE CAPITAL MANAGEMENT, L.P., 333 SOUTH GRAND AVE, 28TH FLOOR, LOS ANGELES CA 90071